Francesco Ramirez Selected Research

Francesco Ramirez Research Topics

Disease

34	Marfan Syndrome (Marfan's Syndrome) 01/2023 - 03/2003
10	Aortic Aneurysm (Aneurysm, Aortic) 01/2023 - 11/2004
10	Thoracic Aortic Aneurysm 01/2023 - 04/2015
6	Aneurysm (Aneurysms) 01/2022 - 03/2006
5	Aortic Dissection 01/2023 - 01/2017
4	Rupture 01/2019 - 01/2008
4	Disease Progression 01/2019 - 11/2005
4	Congenital contractural arachnodactyly 05/2016 - 11/2007
3	Aortic Diseases 01/2022 - 01/2017
2	Bone Resorption 01/2016 - 10/2010
2	Contracture 06/2015 - 06/2010
2	Fibrosis (Cirrhosis) 03/2011 - 12/2010
2	Vascular Diseases (Vascular Disease) 12/2010 - 07/2010
2	Inborn Genetic Diseases (Disease, Hereditary) 08/2010 - 06/2010
2	Hypertension (High Blood Pressure) 12/2009 - 04/2006
1	Tendinopathy (Tendonitis) 11/2019
1	Ascending Aorta Dissection 01/2018
1	Hypertrophy 06/2015
1	Muscular Dystrophies (Muscular Dystrophy) 06/2015
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 03/2014
1	Liver Cirrhosis (Hepatic Cirrhosis) 12/2013
1	Perinatal Death 08/2012
1	Metabolic Bone Diseases (Osteopenia) 12/2010
1	Stiff Skin Syndrome 12/2010
1	Peripheral Nervous System Diseases (PNS Diseases) 06/2010
1	Supravalvular Aortic Stenosis (Aortic Supravalvular Stenosis) 12/2009
1	Carcinoma (Carcinomatosis) 04/2009
1	Abdominal Aortic Aneurysm 01/2008
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 02/2007
1	Muscular Diseases (Myopathy) 02/2007
1	Osteosarcoma (Osteogenic Sarcoma) 03/2006
1	Ehlers-Danlos Syndrome (Syndrome, Ehlers-Danlos) 07/2004
1	Urinary Bladder Neoplasms (Bladder Cancer) 08/2003
1	Emphysema 03/2003

Drug/Important Bio-Agent (IBA)

28	Fibrillin-1IBA 02/2022 - 03/2003
8	Transforming Growth Factor beta (TGF-beta)IBA 01/2017 - 03/2003
6	Losartan (Cozaar)FDA LinkGeneric 01/2023 - 04/2006
5	FibrillinsIBA 05/2016 - 06/2010
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2014
4	ElastinIBA 10/2016 - 11/2004
4	Fibrillin-2IBA 06/2015 - 11/2007
2	RNA (Ribonucleic Acid)IBA 01/2023 - 08/2003
2	Angiotensin IIIBA 01/2022 - 01/2019
2	Type 1 Angiotensin ReceptorIBA 01/2018 - 04/2006
2	Extracellular Matrix ProteinsIBA 01/2016 - 02/2009
2	Neutralizing AntibodiesIBA 04/2015 - 04/2006
2	CollagenIBA 03/2011 - 07/2004
1	Small Cytoplasmic RNAIBA 01/2023
1	Protein Kinases (Protein Kinase)IBA 01/2021
1	Adrenergic Antagonists (Antiadrenergic Agents)IBA 01/2019
1	Baclofen FDA LinkGeneric 01/2019
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	1,3,4,6- tetra- O- acetyl- 2- azido- 2- deoxyglucopyranose (TAAD)IBA 01/2018
1	Versicans (Versican)IBA 01/2018
1	Proteoglycans (Proteoglycan)IBA 01/2018
1	Aggrecans (Aggrecan)IBA 01/2018
1	microfibrillar proteinIBA 11/2015
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 06/2015
1	Myosins (Myosin)IBA 06/2015
1	Smad Proteins (Mothers Against Decapentaplegic Homolog)IBA 04/2015
1	Transforming Growth Factors (Transforming Growth Factor)IBA 04/2015
1	AngiotensinsIBA 04/2015
1	AcetaldehydeIBA 12/2013
1	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2011
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 12/2010
1	IntegrinsIBA 12/2010
1	p38 Mitogen-Activated Protein KinasesIBA 02/2009
1	Matrix Metalloproteinases (MMPs)IBA 01/2008
1	Doxycycline (Periostat)FDA LinkGeneric 01/2008
1	DystrophinIBA 02/2007
1	Plasminogen Activators (Plasminogen Activator)IBA 03/2006
1	Cysteine (L-Cysteine)FDA Link 03/2006
1	Angiogenic ProteinsIBA 03/2006
1	activin AIBA 03/2006
1	ElementsIBA 03/2006
1	DNA (Deoxyribonucleic Acid)IBA 03/2006
1	Transcription Factors (Transcription Factor)IBA 08/2003

Therapy/Procedure

8	Therapeutics 01/2022 - 11/2004